RenuviaMD® Research

A Principal Investigator to lead your trials in Florida

GCP-certified, ICH-GCP Principal Investigator available to research sites and networks across South and Central/West Coast Florida.

Why RenuviaMD® Research

A credentialed PI for your research site

Direct investigator involvement, broad Florida population access, and operations grounded in ICH-GCP — available to partner sites and networks.

Direct PI oversight

Dr. Armando A. Falcon, MD serves as Principal Investigator across both regions — not delegated, hands-on investigator leadership.

Dual-region reach

South Florida and Central/West Coast Florida (Tampa Bay, Orlando), giving sponsors broad and diverse population access.

ICH-GCP operations

GCP-certified, FDA 1572 experience, and phase-level study execution — built for sponsor and CRO expectations.

Therapeutic Snapshot

Where we have documented experience

Lead experience in metabolic, respiratory, and cardiovascular research, with broader clinical capability across cardiometabolic and endocrine care.

Metabolic / Endocrine Active

GLP-1 / GIP therapy, type 2 diabetes, obesity, metabolic syndrome — active Phase I metabolic program.

Respiratory Completed

COPD and chronic bronchitis — completed Phase III trial experience.

Cardiovascular Active

Stroke, atrial fibrillation, and cardiometabolic risk.

See full therapeutic focus

For Research Sites & Partners

Need a qualified PI for your Florida trials?

Oversight scope, feasibility, and capabilities are shared privately under a confidentiality agreement. Sponsors and CROs welcome.